HomeADCT • NYSE
add
ADC Therapeutics SA
Previous close
$3.11
Day range
$3.08 - $3.24
Year range
$1.05 - $3.97
Market cap
357.75M USD
Avg Volume
677.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 18.84M | 8.21% |
Operating expense | 49.06M | 8.46% |
Net income | -56.65M | -55.01% |
Net profit margin | -300.68 | -43.25% |
Earnings per share | — | — |
EBITDA | -30.69M | -6.89% |
Effective tax rate | -2.26% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 264.56M | -11.85% |
Total assets | 321.56M | -13.51% |
Total liabilities | 520.74M | 3.44% |
Total equity | -199.18M | — |
Shares outstanding | 112.50M | — |
Price to book | -1.75 | — |
Return on assets | -26.14% | — |
Return on capital | -33.52% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -56.65M | -55.01% |
Cash from operations | -24.09M | 26.66% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 93.78M | -4.98% |
Net change in cash | 69.86M | 6.11% |
Free cash flow | -8.51M | 69.06% |
About
Founded
2011
Website
Employees
264